The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision.
At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback